12 active trials 9 recruiting 1 Phase 3 10 disease areas 2 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Primary completion pushed from Dec 31, 2026 to Mar 31, 2027
Also in this update: Completion pushed from Jun 30, 2027 to Sep 30, 2027
Guangzhou Lupeng Pharmaceutical Company LTD.Phase 1 NCT04993690 Registry history of NCT04993690 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 6 | |
| Phase 1/2 | 1 | |
| Phase 2 | 4 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07377578 | A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With… | Mantle Cell Lymphoma | Recruiting | 2026-02-06 |
| Phase 2 | ||||
| NCT07776743 | A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis | Relapsing-remitting Multiple Sclerosis (RRMS) | Recruiting | 2026-08-20 |
| NCT07609823 | A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL | Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Recruiting | 2026-07-30 |
| NCT07189065 | A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large… | Diffuse Large B-Cell Lymphoma (DLBCL) | Recruiting | 2025-12-16 |
| NCT05716087 | A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma | Mantle Cell Lymphoma (MCL) | Active, Not Recruiting | 2026-01-15 |
| Phase 1/2 | ||||
| NCT07609862 | A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies | Mantle Cell Lymphoma (MCL) | Recruiting | 2026-07-30 |
| Phase 1 | ||||
| NCT04993690 | A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma | B-cell Lymphoma | Recruiting | 2026-09-14 |
| NCT05641259 | A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In… | Acute Myeloid Leukemia | Recruiting | 2026-09-11 |
| NCT07570017 | A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory… | DLBCL | Recruiting | 2026-09-10 |
| NCT07374224 | A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic… | Clinical Pharmacology | Recruiting | 2026-03-09 |
| NCT06251180 | Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed… | B-cell Non-Hodgkin Lymphoma | Active, Not Recruiting | 2026-09-11 |
| NCT05130567 | A Study of LP-128 Capsules in Healthy Subjects | Chronic Hepatitis b | Active, Not Recruiting | 2025-04-03 |
Non-Hodgkin Lymphoma (4) · DLBCL (3) · Leukemia (3) · Mantle Cell Lymphoma (3) · Chronic Lymphocytic Leukemia (CLL) (2) · Acute Myeloid Leukemia (AML) (1) · Follicular Lymphoma (1) · MDS/MPN Overlap (1) · Multiple Sclerosis (1) · Myelodysplastic Syndromes (MDS) (1)